Carregant...
Dual epigenetic modifiers for cancer therapy
Epigenetic drug discovery is an emerging strategy for the treatment of cancer and other pathologies. Here, we discuss our recent discovery of first-in-class dual reversible inhibitors of the histone methyltransferase activity of G9a/EHMT2 and DNA methyltransferases showing in vivo efficacy in human...
Guardat en:
| Publicat a: | Mol Cell Oncol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5540207/ https://ncbi.nlm.nih.gov/pubmed/28868353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2017.1342748 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|